Table 1.
Changes in physiological indices, oxidative stress factors after QRQZ treatment.
| Biochemical Parameters | Control | Model | PPC | LD-QRQZ | MD-QRQZ | HD-QRQZ | |
|---|---|---|---|---|---|---|---|
| Liver lipid profile | TC (μmol/g prot) | 82.8 ± 21.8 | 161.6 ± 41.6## | 93.9 ± 36.9** | 113.7 ± 28.4* | 92.6 ± 32.8** | 91.9 ± 38.8** |
| TG (μmol/g prot) | 120.2 ± 27.4 | 817.0 ± 51.7## | 309.8 ± 40.4** | 721.2 ± 38.6** | 581.0 ± 50.4** | 514.3 ± 53.3** | |
| Liver function | ALT (U/L) | 31.4 ± 14.1 | 207.0 ± 27.8## | 71.4 ± 33.3** | 172.6 ± 45.0 | 143.6 ± 25.1** | 99.7 ± 46.4** |
| AST (U/L) | 79.8 ± 24.6 | 216.7 ± 39.6## | 134.2 ± 57.0** | 178.1 ± 50.9 | 164.2 ± 56.3* | 150.0 ± 42.9** | |
| Oxidative stress | SOD (U/mg prot) | 196.4 ± 19.4 | 101.5 ± 33.0## | 166.0 ± 20.8** | 129.5 ± 21.0* | 146.2 ± 19.6** | 153.6 ± 17.7** |
| MDA (nmol/mg prot) | 5.5 ± 1.0 | 21.0 ± 1.9## | 10.8 ± 2.2** | 16.1 ± 2.6** | 13.7 ± 2.8** | 12.6 ± 1.5** | |
| GSH-Px (U/mg prot) | 48.2 ± 4.5 | 25.4 ± 3.1## | 37.5 ± 1.7** | 28.5 ± 2.0* | 30.0 ± 2.9** | 32.0 ± 3.3** |
Control, Model, PPC, LD-QRQZ, MD-QRQZ and HD-QRQZ (n = 10 per group) groups. Data are presented as the mean ± standard deviation. ##P < 0.01 as compared to the Control group; *P < 0.05 as compared to the Model group; **P < 0.01 as compared to the Model group.